These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 86163)

  • 21. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
    Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
    Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
    Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
    Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
    Schultz H; Sell A; Nørgaard-Pedersen B; Arends J
    Cancer; 1978 Nov; 42(5):2182-6. PubMed ID: 82474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
    Lange PH; Nochomovitz LE; Rosai J; Fraley EE; Kennedy BJ; Bosl G; Brisbane J; Catalona WJ; Cochran JS; Comisarow RH; Cummings KB; deKernion JB; Einhorn LH; Hakala TR; Jewett M; Moore MR; Scardino PT; Streitz JM
    J Urol; 1980 Oct; 124(4):472-8. PubMed ID: 6158584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of serum ferritin level in testicular tumors].
    Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
    Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of seminoma: does a positive HCG influence prognosis?
    Bartsch G; Mikuz G; Frommhold H; Scheiber K
    Prog Clin Biol Res; 1985; 203():483-4. PubMed ID: 2421340
    [No Abstract]   [Full Text] [Related]  

  • 28. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
    Javadpour N; McIntire KR; Waldmann TA
    Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method].
    Miki T
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):503-22. PubMed ID: 6206269
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
    Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
    Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologic tumor markers in management of testicular and bladder cancer.
    Javadpour N
    Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum alpha1-fetoprotein and H.C.G. in patients with testicular tumours.
    Newlands ES; Dent J; Kardana A; Searle F; Bagshawe KD
    Lancet; 1976 Oct; 2(7988):744-5. PubMed ID: 61427
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pregnancy-specific beta 1-glycoprotein: a tumor marker].
    Horne CH; Bremner RD
    Ric Clin Lab; 1984; 14 Suppl 2():33-8. PubMed ID: 6085182
    [No Abstract]   [Full Text] [Related]  

  • 34. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Morris MJ; Bosl GJ
    J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of human chorionic gonadotropin and alpha-fetoprotein radioimmunoassays: specificity and apparent half-life determination after delivery and in patients with germ cell tumors.
    Mann K; Lamerz R; Hellmann T; Kümper HJ; Staehler G; Karl HJ
    Oncodev Biol Med; 1980; 1(4-5):301-12. PubMed ID: 6169065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biological markers in testicular cancer].
    Glait HM; Carugati A; Scorticati C; Koss A; Bellora O; Mickiewicz E; Arturi J; Olivari AJ
    Medicina (B Aires); 1982; 42(5):488-94. PubMed ID: 6188940
    [No Abstract]   [Full Text] [Related]  

  • 37. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
    Fizazi K; Culine S; Kramar A; Amato RJ; Bouzy J; Chen I; Droz JP; Logothetis CJ
    J Clin Oncol; 2004 Oct; 22(19):3868-76. PubMed ID: 15302906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
    Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
    Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.